John B. Henneman, III

John B. Henneman, III

Lead Independent DirectoratAnika Therapeutics· In proxies 2023–2025

John B. Henneman, III is Lead Independent Director of Anika Therapeutics.

Experience

  1. Anika TherapeuticsPublic company · 3 yr
    • Lead Independent Director2023 – Present · 3 yrStock in role -24%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?